In addition, our study showed the expression of MSH6, MLH1 and PMS2 gene exerted positive influences on OS of late-stage and poor-differentiated ovarian cancer patients, but not of early stage and well-differentiated ovarian cancer patients. Here, PMS2 is linked to ovarian carcinoma.